Menopur 75 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26F0A1W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,001
Award facts
- Contract value 100% obligated
- $23,001.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 26, 2026, for the supply of Menopur 75 Unit Vials, a fertility medication. This competitively awarded, non-set-aside contract carries a ceiling value of approximately $23,000 and is structured as a firm fixed-price delivery order with an ultimate completion date of January 27, 2026. The work will be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 million through December 2031, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The parent company, Cencora, Inc., maintains a significant portfolio of federal pharmaceutical supply contracts and demonstrates substantial capability in fulfilling government medical commodity requirements across multiple therapeutic domains. This delivery order exemplifies the company's role in supporting military treatment facilities and federal healthcare institutions with specialized pharmaceutical products required for troop medical readiness and healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F0A1W?
SPE2DR26F0A1W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F0A1W worth?
The government has obligated $23,001 on SPE2DR26F0A1W.
Is contract SPE2DR26F0A1W an order under another contract?
Yes. SPE2DR26F0A1W is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0A1W competed?
The extent of competition for SPE2DR26F0A1W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award